ArticleNeurotoxicology2025
Neurobehavioral and metabolic effects of prenatal low-dose chlorpyrifos in C57BL/6J mice.
Article in Neurotoxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Chlorpyrifos is an organophosphorus insecticide known to produce severe neurotoxicity following early developmental exposure. So far, little data describes the neurobehavioral and metabolic consequences of low-dose exposures, near the threshold to produce cholinesterase inhibition. The purpose of the current study was to characterize the impact of prenatal exposure to a low dose of chlorpyrifos, at 0.5 mg/kg/day, and compare observed neurobehavioral and metabolic changes to a well-defined daily dose of 5 mg/kg. Pregnant C57BL/6 J dams were exposed to either 0, 0.5, or 5 mg/kg/day chlorpyrifos from gestation day 6.5-17.5. A metabolic profile was determined in dams and pups at the end of exposure and behavior was analyzed in offspring during late adolescence and early adulthood. Exposure to 5 mg/kg chlorpyrifos disrupted metabolites associated with the oxidative stress response and with energy metabolism within the brain and produced long-term impairment in spontaneous behavior and learning in offspring. Exposure to the lower dose of 0.5 mg/kg/day reduced levels of metabolites downstream of ornithine, a process that was also disrupted with exposure to 5 mg/kg/day. Further, 0.5 mg/kg/day chlorpyrifos impaired spontaneous behavior in offspring during adulthood, though no significant effects on learning or reversal were seen. These findings support a conclusion that prenatal low dose chlorpyrifos exposure produces long-term metabolic and neurobehavioral impairment that resemble deficits seen with high dose exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.